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SUMMARY 
The dexamethasone suppression test was administered to five patients with post-stroke depression, at initial 
evaluation and also in follow-up. It showed parallel results to clinical course of depression in four out of five patients. 
Depression following stroke has been 
recognized as a common and potentially 
serious complication (Agarwal et al., 1987; 
Robinson et al., 1984). It is a reversible 
and treatable condition and effectiveness of 
imipramine in treatment of depression after 
stroke has been shown (Agarwal et al., 1986). 
Initially there have been some problems in 
diagnosis of post-stroke depression (Feibel 
et al., 1979), but recently an abnormal 
dexamethasone suppression test (DST) res-
ponse, a robust biological characteristic of 
depression (WHO Collaborative Study, 1987) 
has been shown to be useful (Agarwal et al., 
1987; Finklestein et al., 1982; Lipsev et al., 
1985). Its role in follow-up of these patients 
and monitoring the progress of patients is 
not clear. 
MATERIAL AND METHODS 
The study comprised of five right handed 
patients of thromboembolic stroke, of more 
than three weeks duration (Table I). After 
detailed general and neurological examina-
tion, these patients were evaluated for asso-
ciated depression. The patients were asked 
about depressed mood (feeling of sadness 
and hopelessness), anxiety, frustration, crying 
and Weeping spells. Enquiries were also 
made about vegetative (sleep and appetite) 
disturbances. These were scored on four 
point scale as nil (0), mild (1), moderate 
(2), and severe (3). 
An overnight DST was administered to 
the patients in ward. One milligram of dexa-
methasone (Wymesone) was given at 2300 
hours and plasma samples were obtained at 
1600 h and 2300 h the following day. Plasma 
Cortisol was measured by radioimmunoassay 
in the Department of Endocrinology, CDRI, 
Lucknow. The DST was considered positive 
if the 1600 or 2300 Cortisol level was more 
than 5.0 /ig/dl (Carroll et al., 1981). All the 
patients were medically stable at the time 
of DST. None was in the process of acute 
withdrawal from alcohol and none had active 
infection, fever, uncontrolled diabetes mellitus 
or any other factor known to produce false 
positive or false negative DST (Carroll et al., 
1981). 
Patients in whom clinical diagnosis of 
depression was made and DST was positive 
(Pt. No. 1 to 3) were kept on imipramine, 
initially in low doses (25-50 mg at bedtime) 
and later its dose was increased to 75 mg 
(Pt. No. 1 and 3) and 10 mg (Pt. No. 2). Pati-
ents were followed up after every two weeks. 
Repeat DST was done in first three patients 
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after 4-6 weeks of imipramine treatment. 
In rest two patients repeat DST was done 
when follow-up evaluation (four and six 
months after stroke respectively) showed 
evidences of depression which Was absent 
at initial examination. 
RESULTS 
The details of five stroke patients studied 
are given in Table II. While DST in the 
course of patient No. 1 and 3 became normal 
after clinical improvement in depression, 
it continued to be abnormal in patient No. 2 
in whom the depression has not much res-
ponded clinically also. He was later given 
higher dose of imipramine (150 mg/day) 
and responded to it. The consent for 
repeat DST was not given this time. Out 
of the remaining two patients, who were found 
to have moderate to severe disturbance of 
mood and vegetative functions in follow-up, 
repeat DST was positive in one patient 
(No. 4) only. 
DISCUSSION 
It has been shown that almost one-third 
of stroke patients show evidences of depres-
sion (Agarwal et al., 1987; Robinson et al., 
1984). Moderate sensitivity and specificity 
of DST has also been reported for post-
stroke depression (Agarwal et al., 1987; 
Lipsey et al., 1985). But the reports about 
its value in folloW-up of these patients are 
scanty. We could get the mention of only 
two patients in literature available to us where 
repeat DST was done in follow-up (Fink-
lestein et al., 1982). It was found to be paral-
lel to the clinical course. 
In this study DST responses were found 
to be parallel to clinical course in four out 
of five patients. One of our patient who 
showed evidence of moderate depression in 
TABLE I. Characteristics of patients 
SI. 
No. 
Age 
(Yrs.) 
Sex 
Hemispheric 
Involvement 
Time since 
stroke (Days) 
Severity of 
weakness 
1. 
2. 
S. 
4, . 
5. 
35 
45 
65 
55 
47 
M 
M 
M 
F 
M 
Lt 
Lt 
Lt 
Lt 
Rt 
28 
.65 
74 
42 
104 
Moderate 
Mild 
Severe 
Moderate 
Moderate 
TABLE II. DST and post-stroke depression 
SI. 
No. 
1. 
2. 
3. 
4. 
5. 
Initial Evaluation 
Depressed 
mood 
3 
3 
3 
1 
0 
Vegetative 
disturbance 
0 
3 
2 
1 
1 
Initial 
DST 
-f-ve 
+ve 
+ ve 
— ve 
— ve 
Follow-up 
Depressed 
mood 
1 
2 
1 
3 
2 
Evaluation 
Vegetative 
disturbance 
0 
3 
0 
2 
2 
Repeat 
DST 
—ve 
-fve 
—ve 
+ve 
— ve 
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follow-up showed negative DST. He was 
having right hemispheric stroke which has 
been found to be less commonly associated 
with positive DST (Agarwal et al., 1987). 
The DST response in the course of major 
depression has not been consistent. Paselow 
et al. (1987) has reported a study of 73 
patients of major depression. He found that 
only 27.4% patients had abnormal DST 
during depression and normal DST after 
recovery. Percentage of patients who had 
abnormal and normal DSTs both the times 
was 8.2 and 58.9 respectively. But they 
reported significantly higher post-dexametha-
sone plasma Cortisol levels during depression 
as compared to that after recovery. Yere-
vanian et al. (1983) have also demonstrated 
strong correlation between improvement in 
depression and reduction in post DST Cor-
tisol level. Albala et al. (1981) reported nor-
malization of DST in all the five (out of six) 
patients of depression who responded to 
electroconvulsive treatment. 
The DST in the course of depressive illness 
has been shown to be of prognostic value as 
well. In DST positive depressed patients 
undergoing treatment, a repeat DST at 
discharge discriminated effectively between 
a good and poor outcome group (Bowie et 
al., 1987; Greden et al., 1983). Those 
patients who had persistent abnormal DST 
even after apparent clinical recovery are 
more likely to relapse than those in whom 
DST normalizes (Greden et al., 1980; Paselow 
et al., 1987; Schweitzer et al., 1987;TheAPA 
Task Force on Laboratory Tests in Psy-
chiatry, 1987). The prognostic usefulness of 
serial DSTs is to be evaluated in post stroke 
depression with long term follow-up. We 
could repeat DST in only a small number 
of patients because of many reasons. One 
of these was requirement of patient's admis-
sion in ward at least for 2 days because of 
odd timings of test (2300 h). If one can do 
with only 1600 plasma Cortisol level, DST can 
be done at OPD level in a greater popula-
tion of patients. Of course, it will reduce 
the sensitivity of test (Carroll et al., 1981). 
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